Apobiologix

Description: Apobiologix®, a division of Apotex Inc., focuses on the commercialization of biosimilars. The Apobiologix® biosimilar program is a natural extension of Apotex' long history of providing access to high-quality, affordable medicines in Canada and across the globe.

We aspire to transform access to affordable therapies in oncology and beyond through innovation, development and partnerships. At Apobiologix®, we believe Invention is not the only Innovation; we believe healthcare providers and patients deserve access to affordable therapies without compromising efficacy, quality, and safety.